T. D. Martinez

[11C]Choline as a PET biomarker for assessment of prostate cancer tumor models.

G. Hutchins, C. Kao, T. Gardner, 2004, Bioorganic & medicinal chemistry.

Comparative studies of potential cancer biomarkers carbon-11 labeled MMP inhibitors (S)-2-(4'-[11C]methoxybiphenyl-4-sulfonylamino)-3-methylbutyric acid and N-hydroxy-(R)-2-[[(4'-[11C]methoxyphenyl)sulfonyl]benzylamino]-3-methylbutanamide.

G. Hutchins, G. Sledge, K. Miller, 2004, Nuclear medicine and biology.

Synthesis, biodistribution and micro-PET imaging of a potential cancer biomarker carbon-11 labeled MMP inhibitor (2R)-2-[[4-(6-fluorohex-1-ynyl)phenyl]sulfonylamino]-3-methylbutyric acid [11C]methyl ester.

G. Hutchins, G. Sledge, T. DeGrado, 2003, Nuclear medicine and biology.

Synthesis of radiolabeled O6‐benzylguanine derivatives as new potential PET tumor imaging agents for the DNA repair protein O6‐alkylguanine‐DNA alkyltransferase

G. Hutchins, K. Miller, Q. Zheng, 2002 .

Synthesis, biodistribution and micro-PET imaging of radiolabeled antimitotic agent T138067 analogues.

G. Hutchins, G. Sledge, K. Miller, 2004, Bioorganic & medicinal chemistry letters.

Synthesis and preliminary biological evaluation of MMP inhibitor radiotracers [11C]methyl-halo-CGS 27023A analogs, new potential PET breast cancer imaging agents.

G. Hutchins, G. Sledge, K. Miller, 2002, Nuclear medicine and biology.